Search research articles
Contact Us
Filters
Showing results (11-20 of 121) with videos related to
Page
of 13
Sort By:
Anticancer Research
|
February 4, 2019
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer
Toshiyuki Seki, Jianyun Liu, Randy R Brutkiewicz, et al.
Expert Review of Anti-Infective Therapy
|
June 18, 2015
Circumsporozoite protein as a potential target for antimalarials
Cristina Fernández-Arias, Sara Mashoof, Jing Huang, et al.
Bio-Protocol
|
August 30, 2016
Generation of Human iNKT Cell Lines
Xiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Bio-Protocol
|
June 10, 2016
Generation of Mouse iNKT Cell Lines
Xiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
The Journal of Experimental Medicine
|
December 6, 2003
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide
John Schmieg, Guangli Yang, Richard W Franck, et al.
F1000Research
|
June 16, 2018
Development of a novel mechanism-based glycolipid adjuvant for vaccination
Jordana Grazziela Coelho-Dos-Reis, Xiangming Li, Moriya Tsuji
Organic Letters
|
October 22, 2004
Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis
Guangwu Chen, John Schmieg, Moriya Tsuji, et al.
Journal of Biomedicine & Biotechnology
|
January 14, 2010
A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer
John Schmieg, Guangli Yang, Richard W Franck, et al.
Clinical Immunology (Orlando, Fla.)
|
December 28, 2010
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant
Neal N Padte, Xiangming Li, Moriya Tsuji, et al.
Immunology Letters
|
June 15, 2017
Human IgG repertoire of malaria antigen-immunized human immune system (HIS) mice
Raquel Tayar Nogueira, Vincent Sahi, Jing Huang, et al.
Page
of 13
Search research articles
Search
Showing results (11-20 of 121) with videos related to
Sort By:
Page
of 13
Anticancer Research
|
February 4, 2019
A Potent CD1d-binding Glycolipid for iNKT-Cell-based Therapy Against Human Breast Cancer
Toshiyuki Seki, Jianyun Liu, Randy R Brutkiewicz, et al.
Expert Review of Anti-Infective Therapy
|
June 18, 2015
Circumsporozoite protein as a potential target for antimalarials
Cristina Fernández-Arias, Sara Mashoof, Jing Huang, et al.
Bio-Protocol
|
August 30, 2016
Generation of Human iNKT Cell Lines
Xiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
Bio-Protocol
|
June 10, 2016
Generation of Mouse iNKT Cell Lines
Xiangming Li, Moriya Tsuji, Jonathan Schneck, et al.
The Journal of Experimental Medicine
|
December 6, 2003
Superior protection against malaria and melanoma metastases by a C-glycoside analogue of the natural killer T cell ligand alpha-Galactosylceramide
John Schmieg, Guangli Yang, Richard W Franck, et al.
F1000Research
|
June 16, 2018
Development of a novel mechanism-based glycolipid adjuvant for vaccination
Jordana Grazziela Coelho-Dos-Reis, Xiangming Li, Moriya Tsuji
Organic Letters
|
October 22, 2004
Efficient synthesis of alpha-C-galactosyl ceramide immunostimulants: use of ethylene-promoted olefin cross-metathesis
Guangwu Chen, John Schmieg, Moriya Tsuji, et al.
Journal of Biomedicine & Biotechnology
|
January 14, 2010
A multifactorial mechanism in the superior antimalarial activity of alpha-C-GalCer
John Schmieg, Guangli Yang, Richard W Franck, et al.
Clinical Immunology (Orlando, Fla.)
|
December 28, 2010
Clinical development of a novel CD1d-binding NKT cell ligand as a vaccine adjuvant
Neal N Padte, Xiangming Li, Moriya Tsuji, et al.
Immunology Letters
|
June 15, 2017
Human IgG repertoire of malaria antigen-immunized human immune system (HIS) mice
Raquel Tayar Nogueira, Vincent Sahi, Jing Huang, et al.
Page
of 13